You need to sign in or sign up before continuing.
Back to History

Fields Changed

Registration

Field Before After
Trial Status in_development on_going
Trial End Date November 16, 2023 September 25, 2024
Last Published January 23, 2023 08:05 AM June 26, 2024 04:47 AM
Intervention End Date April 13, 2023 September 25, 2024
Planned Number of Observations 1860 participants in Wave 1 and 3384 participants in Wave 2 1860 participants in Wave 1 and 3384 participants in Wave 2 Update June 2024: plus 300 participants in Wave 1 and 200 participants in Wave 2 (see below).
Sample size (or number of clusters) by treatment arms In Wave 1 we plan to have 240 participants per treatment except for the conditions where each individual is uniquely observed by twenty others in Wave 2. For those conditions we plan on 60 participants in Wave 1. The reason is that otherwise Wave 2 sample sizes would become extremely large. (240 Wave 1 participants in this condition would correspond to 4800 Wave 2 participants for this condition alone). We will have 300 participants (240+60) in the baseline treatment (without influence/observability). In sum we will have the following sample sizes for our Wave 1 treatments: Baseline: 300; Influence 1-1: 240; Influence 1-20: 60; Influence 20-1: 240; Influence 20-20: 240 Observability 1-1: 240; Observability 1-20: 60; Observability 20-1: 240; Observability 20-20: 240, where Influence x-y denotes an influence treatment where each Wave 1 participant is observed by x others who each observe y others in total. Sample sizes in Wave 2 then directly follow from these. In Wave 1 we plan to have 240 participants per treatment except for the conditions where each individual is uniquely observed by twenty others in Wave 2. For those conditions we plan on 60 participants in Wave 1. The reason is that otherwise Wave 2 sample sizes would become extremely large. (240 Wave 1 participants in this condition would correspond to 4800 Wave 2 participants for this condition alone). We will have 300 participants (240+60) in the baseline treatment (without influence/observability). In sum we will have the following sample sizes for our Wave 1 treatments: Baseline: 300; Influence 1-1: 240; Influence 1-20: 60; Influence 20-1: 240; Influence 20-20: 240 Observability 1-1: 240; Observability 1-20: 60; Observability 20-1: 240; Observability 20-20: 240, where Influence x-y denotes an influence treatment where each Wave 1 participant is observed by x others who each observe y others in total. Sample sizes in Wave 2 then directly follow from these. Update June 2024: After conducting the study the effect size for OBS(1,1) was slightly bigger than conjectured and as a result the difference between INF(1,1) and OBS(1,1) not statistically significant at conventional levels (p=0.1219). We propose to increase the sample size by 500 participants (100 participants each in baseline, INF(1,1) and OBS(1,1) and as a consequence also an additional 200 Wave-2 participants) to be able to detect also this slightly smaller effect size.
Back to top